NCT00546845Unknown4 期
Xpert Stent Versus Balloon Angioplasty in Complex Lesions of Small Arteries Below the Knee
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 180
- 试验地点
- 2
- 主要终点
- MLD at the target lesion assessed by angiography
研究概览
简要总结
This study is an investigator-initiated study. The study will be performed as a prospective, randomized, controlled multi-center trial to evaluate the safety and efficiency of Xpert stents compared to PTA in patients with chronic distal artery occlusions or stenosis undergoing catheter revascularization. Patients will be eligible for randomization if they are over 18 years old, if they undergo percutaneous catheter revascularization of an artery below the knee stenosis/occlusion that is less than 15 centimeters in length. Up to two vessels may be treated in this study. All lesions greater than 50% in the below the knee artery region have to be treated either with PTA or stenting according to the randomization.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •1. Age between 18 and 95 years.
- •Subject or subject's legal representative have been informed of the nature of the study, and have signed the patient informed consent form. Patient is willing to take part in the follow-up protocol of the XXS study.
- •3. Rutherford stage 4 and 5 Anatomical:
- •Additional lesions inflow lesions might be successfully treated before randomization and treatment of the target lesion. The inflow lesions which were treated before randomization should only be classified TASC A or B. (TASC= Trans Atlantic Intersociety Conference)
- •Target vessel with documented run-off to the foot distally of the index lesion with patent plantar arteries
- •Reference vessel diameter of the target lesion should be ≥ 2 and ≤ 5 mm.
- •Maximum treated length in the target vessel is 15 cm (might also be divided up into multiple segments with up to 3 different lesions being treated).
- •Maximum of treated vessels per leg below the knee: 2 (all treated vessels should be treated within the randomization to the study group [PTA or stenting]).
- •Minimum distance target lesion to talus is 5 cm.
排除标准
- •Life expectancy due to a non-atheroslerotic disease less than 12 months.
- •Previous bypass surgery < 30 days prior to the study procedure.
- •Known allergies or sensitivities to heparin, contrast media, aspirin, clopidogrel, and nitinol which cannot be treated with antihistamines.
- •eGFR less than 29 mL/min/1.73m2 (K-DOQI Class 4 and 5) in patients which are not currently treated with dialysis (equivalent to a serum creatinine level of 2.4 mg/dL in a 70 year old male patient)
- •Subject with breast feeding plans, or child bearing potential with no birth control.
- •Subjects enrolled in another study concerning the index vessel(s) within 3 months prior to the study procedure.
- •Untreatable bleeding diatheses.
- •Patients who have an indication of being treated with coumadin after the intervention.
- •Inability to ambulate
- •Hypercoagulable state
- •Patients with age <18 years and patients who are not able to sign the informed consent form
- •Anatomical:
- •Inflow is obstructed and cannot be successfully treated prior to randomization and treatment of below the knee arteries.
- •Acute thrombus present in the target limb.
- •Previously implanted stent in the target vessel(s).
- •Aneurysms in the index leg.
- •Index vessel with no documented run-up to the foot (please also see inclusion criteria, anatomical).
- •Inability to use femoral access
- •No patent pedal arteries
结局指标
主要结局
MLD at the target lesion assessed by angiography
时间窗: after 12 +/-2 months
treatment effect dependent if stent of PTA was choosen
次要结局
- 1. Interventional success rate. Interventional success is defined as restenosis less than 50%. 2. Late lumen loss (LLL)(after 1, 6, 12 months and 3 years)
- 3. Binary restenosis(arter 6, 12 months and 3 years)
- 4. Number of patients initially randomized to the PTA group, but receiving stents because of the suboptimal interventional success.(intervention)
- Target lesion revascularization, clinical stage, hospital days(after 1, 6, 12 months, and 3 years)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic ShockComplicationsAcute Myocardial InfarctionCardiogenic ShockNCT01927549University of Luebeck706
Unknown
3 期
Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total OcclusionsChronic Total Occlusion of Artery of the ExtremitiesNCT01268722University of Patras150
已完成
不适用
Pivotal Study for the FLAIR Endovascular Stent GraftStenosesNCT00678249C. R. Bard227
Unknown
不适用
DCB Compared Stenting in Popliteal LesionsPopliteal StenosisPopliteal Artery OcclusionDiabetesNCT03739580Xuanwu Hospital, Beijing80
已完成
不适用
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal ArteriesPeripheral Artery DiseaseNCT02522884Philips Clinical & Medical Affairs Global213